We identified 171 consecutive patients diagnosed with untreated metastatic nonsquamous PD-L1-positive NSCLC who had undergone the ACN or CN regimen, of whom 47 were excluded in accordance with the eligibility criteria. This evidence concerns the gene CD274 and non-small cell lung carcinoma.